AMPEL BioSolutions COO Dr Amrie Grammer chatted with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Charlottesville, Virginia-based company can identify drugs for treating lupus patients. According to its website, the company’s system can be applied to any disease.
AMPEL BioSolutions Focused on Developing Clinical Blood Test Predicts the Correct Drug for a Patient
Date: February 11, 2022